Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative night dexmedetomidine nasal spray for prevention of postoperative delirium after hip replacement in elderly patients
ChiCTR2600122404Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD), Insomnia and postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Incidence of postoperative delirium. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)Insomniapostoperative pain
Beyond the preview
Go deeper on ChiCTR2600122404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122404.